StockData
Palisade Bio, Inc. logo

Palisade Bio, Inc. (PALI) stock

PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$0.94−0.07 (-6.72%)

Close on Nov 18, 2026Market cap $164.18MP/E –Yield –

Palisade Bio operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Palisade Bio's operating income for the twelve months ending Jun 30, 2026 was -$35.35M. For fiscal 2025 it was -$18.06M. The highest annual figure on record is -$8.26M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$18.06M–
FY2024Dec 31, 2024-$14.86M–
FY2023Dec 31, 2023-$13.07M–
FY2022Dec 31, 2022-$15.72M–
FY2021Dec 31, 2021-$41.85M–
FY2020Dec 31, 2020-$9.30M–
FY2019Dec 31, 2019-$8.63M–
FY2018Dec 31, 2018-$8.26M–
FY2017Dec 31, 2017-$13.31M–
FY2016Dec 31, 2016-$20.64M–
FY2015Dec 31, 2015-$19.16M–
FY2014Dec 31, 2014-$17.44M–
FY2013Dec 31, 2013-$12.52M–
FY2012Dec 31, 2012-$10.16M–
FY2011Dec 31, 2011-$12.99M–
FY2010Dec 31, 2010-$15.18M–
FY2009Dec 31, 2009-$10.47M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$11.70M–
Q1 FY2026Mar 31, 2026-$10.75M–
Q4 FY2025Dec 31, 2025-$9.98M–
Q3 FY2025Sep 30, 2025-$2.92M–
Q2 FY2025Jun 30, 2025-$2.84M–
Q1 FY2025Mar 31, 2025-$2.31M–
Q4 FY2024Dec 31, 2024-$3.38M–
Q3 FY2024Sep 30, 2024-$3.59M–
Q2 FY2024Jun 30, 2024-$4.21M–
Q1 FY2024Mar 31, 2024-$3.67M–
Q4 FY2023Dec 31, 2023-$3.15M–
Q3 FY2023Sep 30, 2023-$3.78M–
Q2 FY2023Jun 30, 2023-$3.61M–
Q1 FY2023Mar 31, 2023-$2.53M–
Q4 FY2022Dec 31, 2022-$3.85M–
Q3 FY2022Sep 30, 2022-$4.41M–
Q2 FY2022Jun 30, 2022-$3.57M–
Q1 FY2022Mar 31, 2022-$3.89M–
Q4 FY2021Dec 31, 2021-$4.03M–
Q3 FY2021Sep 30, 2021-$3.02M–
Q2 FY2021Jun 30, 2021-$32.86M–
Q1 FY2021Mar 31, 2021-$1.95M–
Q4 FY2020Dec 31, 2020-$3.25M–
Q3 FY2020Sep 30, 2020-$1.82M–
Q2 FY2020Jun 30, 2020-$1.84M–
Q1 FY2020Mar 31, 2020-$1.99M–
Q4 FY2019Dec 31, 2019-$2.13M–
Q3 FY2019Sep 30, 2019-$2.12M–
Q2 FY2019Jun 30, 2019-$1.92M–
Q1 FY2019Mar 31, 2019-$2.46M–
Q4 FY2018Dec 31, 2018-$1.80M–
Q3 FY2018Sep 30, 2018-$2.08M–
Q2 FY2018Jun 30, 2018-$2.02M–
Q1 FY2018Mar 31, 2018-$2.35M–
Q4 FY2017Dec 31, 2017-$2.27M–
Q3 FY2017Sep 30, 2017-$2.59M–
Q2 FY2017Jun 30, 2017-$4.22M–
Q1 FY2017Mar 31, 2017-$4.23M–
Q4 FY2016Dec 31, 2016-$5.65M–
Q3 FY2016Sep 30, 2016-$4.92M–

More Palisade Bio figures

See a number that looks wrong?